Back to Search Start Over

Tyrosinemia type III in an asymptomatic girl

Authors :
Dariusz Rokicki
Anna Tylki-Szymańska
Malgorzata Sredzinska
Elżbieta Ciara
Rafał Płoski
Dorota Piekutowska-Abramczuk
Edyta Szymańska
Source :
Molecular Genetics and Metabolism Reports, Molecular Genetics and Metabolism Reports, Vol 5, Iss C, Pp 48-50 (2015)
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29–86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the HPD gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3.

Details

ISSN :
22144269
Volume :
5
Database :
OpenAIRE
Journal :
Molecular Genetics and Metabolism Reports
Accession number :
edsair.doi.dedup.....3463cf634e635a95bd6721eec87cdfcd
Full Text :
https://doi.org/10.1016/j.ymgmr.2015.10.004